Maria Khan Junaidi: How Age Influences Intracerebral Hemorrhage Outcomes
Maria Khan Junaidi, Deputy Program Director Vascular Neurology at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in European Stroke Journal, adding:
“Pleased to share our latest publication in the European Stroke Journal.
Clinical characteristics and outcomes of intracerebral haemorrhage in young vs. older adults: Insights from the INTERACT3 trial.
In this secondary analysis of 7,031 patients across 10 countries, we found that although younger adults (լess than or equal to 50 years) with ICH often had larger haematomas and a distinct vascular risk profile, they experienced significantly better 6-month outcomes and appeared to derive greater benefit from bundled acute ICH care.
These findings reinforce the importance of early, protocol-driven management while highlighting the need for targeted prevention strategies in younger patients with ICH.
Grateful to all collaborators and the INTERACT3 investigators for making this work possible.”
Title: Clinical characteristics and outcomes of intracerebral haemorrhage in young vs older adults: insights from the INTERACT3 trial
Authors: Maria Khan, Menglu Ouyang, Mohammad Wasay, Lu Ma, Xin Hu, Xiaoying Chen, Laurent Billot, Qiang Li, Paula Muñoz Venturelli, Asita de Silva, Nguyen Huy Thang, Kolawole W Wahab, Jeyaraj D Pandian, Octavio M Pontes-Neto, Carlos Abanto, Antonio Arauz, Chao You, Lili Song, Craig S Anderson
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 2, 2026, 11:17Heghine Khachatryan: Novel Biomarkers for Cancer-Associated Thrombosis
-
Jul 2, 2026, 11:17Neeraj Jain: Maharashtra Is Setting the Pace for Integrated Hemoglobinopathy Care
-
Jul 2, 2026, 11:11Safaa Hilal: Improving Postpartum Hemorrhage Outcomes Through Early Warning Scores
-
Jul 2, 2026, 10:58Heghine Khachatryan: What Is Your Position on the Voluntary or Financially Compensated Blood Donation Model
-
Jul 2, 2026, 10:51Faces of Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jul 2, 2026, 10:44Priya Sriskandarajah: Understanding Anemia of Chronic Disease in Clinical Practice
-
Jul 2, 2026, 10:42Flora Peyvandi: Germline-Targeting Vaccines for HIV
-
Jul 2, 2026, 10:29Nisar Ahmed: The Evolution of Anticoagulation Therapy
-
Jul 2, 2026, 09:24Paschalis Evangelidis: Presenting Real-World Evidence to Improve Outcomes in TMA at EHA 2026